With the help of sophisticated sequencing technologies, scientists are able to detect mutations, gene amplifications, and structural alterations that cause tumor growth. This information enables doctors to personalize treatment to address particular genetic abnormalities, making treatments more effective and reducing side effects. Cancer genomics is also important in the detection of biomarkers for prognosis, monitoring response to treatment, and detecting minimal residual disease.
The session touches on precision oncology applications in targeted therapies, immunotherapy, and combination therapies driven by genomic information. New technologies like next-generation sequencing, single-cell genomics, and bioinformatics are increasing our capacity to decipher tumor complexity and make sense of heterogeneity across and within tumors.
Participants will learn about the fundamental principles of cancer genomics, day-to-day applications in patient management, and cutting-edge research that will define the future of oncology. This session emphasizes how genomic data is revolutionizing cancer diagnosis, choice of therapy, and monitoring of disease, leading to more personalized, efficient, and data-driven cancer treatment.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
